000 | 01671 a2200505 4500 | ||
---|---|---|---|
005 | 20250514193625.0 | ||
264 | 0 | _c20041221 | |
008 | 200412s 0 0 eng d | ||
022 | _a1526-632X | ||
024 | 7 |
_a10.1212/01.wnl.0000132841.81250.b7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aClarke, C E | |
245 | 0 | 0 |
_aTremor and deep white matter changes in alpha-methylacyl-CoA racemase deficiency. _h[electronic resource] |
260 |
_bNeurology _cJul 2004 |
||
300 |
_a188-9 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article; Review | ||
650 | 0 | 4 |
_aBrain _xpathology |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aDepressive Disorder _xcomplications |
650 | 0 | 4 |
_aDysarthria _xenzymology |
650 | 0 | 4 | _aElectroencephalography |
650 | 0 | 4 |
_aFatty Acids _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMagnetic Resonance Imaging |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aParesis _xetiology |
650 | 0 | 4 |
_aPeroxisomal Disorders _xdiet therapy |
650 | 0 | 4 |
_aPhytanic Acid _xadministration & dosage |
650 | 0 | 4 | _aPlasma Exchange |
650 | 0 | 4 |
_aRacemases and Epimerases _xdeficiency |
650 | 0 | 4 | _aReflex, Abnormal |
650 | 0 | 4 |
_aRetinitis Pigmentosa _xenzymology |
650 | 0 | 4 | _aTreatment Failure |
650 | 0 | 4 |
_aTremor _xetiology |
700 | 1 | _aAlger, S | |
700 | 1 | _aPreece, M A | |
700 | 1 | _aBurdon, M A | |
700 | 1 | _aChavda, S | |
700 | 1 | _aDenis, S | |
700 | 1 | _aFerdinandusse, S | |
700 | 1 | _aWanders, R J A | |
773 | 0 |
_tNeurology _gvol. 63 _gno. 1 _gp. 188-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1212/01.wnl.0000132841.81250.b7 _zAvailable from publisher's website |
999 |
_c14952690 _d14952690 |